# XYLOCAINE

NDC: 51662-1622
Generic name: XYLOCAINE
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INFILTRATION, PERINEURAL
Marketing started: 20100812

FDA application: NDA006488

## Active ingredients

- EPINEPHRINE BITARTRATE: .01 mg/mL
- LIDOCAINE HYDROCHLORIDE ANHYDROUS: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1622"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1622
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17e77013-f2a0-b1f7-e063-6294a90ae468